|
显示项目 738971-738980 / 2348487 (共234849页)
<< < 73893 73894 73895 73896 73897 73898 73899 73900 73901 73902 > >>
每页显示[10|25|50]项目
| 慈濟大學 |
2010 |
Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells
|
Chiu, Shu-Jun;Hsaio, Ching-Hui;Tseng, Ho-Hsing;Su, Yu-Han;Shih, Wen-Ling;Lee, Jeng-Woei;Chuah, Jennifer Qiu-Yu |
| 東海大學 |
2010 |
Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells
|
Chiu, S.-J.ab , Hsaio, C.-H.a, Tseng, H.-H.a, Su, Y.-H.a, Shih, W.-L.c, Lee, J.-W.a, Chuah, J.Q.-Y.a |
| 東海大學 |
2010 |
Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells
|
Chiu, S.-J.ab , Hsaio, C.-H.a, Tseng, H.-H.a, Su, Y.-H.a, Shih, W.-L.c, Lee, J.-W.a, Chuah, J.Q.-Y.a |
| 國家衛生研究院 |
2019-05-14 |
Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients
|
Tseng, CH |
| 臺大學術典藏 |
2020-06-01T08:33:24Z |
Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients
|
CHIN-HSIAO TSENG; Chin-Hsiao Tseng |
| 國家衛生研究院 |
2023-07-25 |
Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients
|
Tseng, CH |
| 國立臺灣大學 |
2007 |
Rosiglitazone in Diabetes Control in Hemodialysis Patients with and without Viral Hepatitis Infection - Effectiveness and Side Effects
|
姜至剛; 何泰儀; 彭渝森; 徐世平; 白玫芬; 楊紹佑; 洪冠予; 吳寬墩; CHIANG, CHIH-KANG; HO, TAI-I; PENG, YU-SEN; HSU, SHIH-PING; PAI, MEI-FEN; YANG, SHAO-YU; HUNG, KUAN-YU; WU, KWAN-DUN |
| 臺大學術典藏 |
2020-11-27T03:24:52Z |
Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: Effectiveness and side effects
|
Chiang C.-K.;Ho T.-I.;Peng Y.-S.;Hsu S.-P.;Pai M.-F.;Yang S.-Y.;Kuan-Yu Hung;Wu K.-D.; Chiang C.-K.; Ho T.-I.; Peng Y.-S.; Hsu S.-P.; Pai M.-F.; Yang S.-Y.; KUAN-YU HUNG; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T05:52:26Z |
Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: Effectiveness and side effects
|
Chiang C.-K.;Ho T.-I.;Peng Y.-S.;Hsu S.-P.;Pai M.-F.;Shao-Yu Yang;Hung K.-Y.;Wu K.-D.; Chiang C.-K.; Ho T.-I.; Peng Y.-S.; Hsu S.-P.; Pai M.-F.; SHAO-YU YANG; Hung K.-Y.; Wu K.-D. |
| 臺大學術典藏 |
2021-08-20T04:14:29Z |
Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: Effectiveness and side effects
|
Chiang C.-K.; Ho T.-I.; Peng Y.-S.; Hsu S.-P.; Pai M.-F.; Yang S.-Y.; KUAN-YU HUNG; Wu K.-D. |
显示项目 738971-738980 / 2348487 (共234849页)
<< < 73893 73894 73895 73896 73897 73898 73899 73900 73901 73902 > >>
每页显示[10|25|50]项目
|
